Following a complete response letter rejecting accelerated approval for RP1 in advanced melanoma, IGNYTE trial investigators are urging the FDA to reevaluate the therapy’s robust survival data, just ...

Thousands of Black Sabbath fans paid their respects to frontman Ozzy Osbourne as his hearse made its way through the streets ...

Spotify’s impressive growth tripped over higher personnel costs. Is this a temporary stumble or a prime buying opportunity?